SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ekblom Kim 1970 )
 

Search: WFRF:(Ekblom Kim 1970 ) > Bilirubin and UGT1A...

  • Ekblom, Kim,1970-Umeå universitet,Klinisk kemi (author)

Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • 2010-10-16
  • S. Karger,2010
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-33753
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-33753URI
  • https://doi.org/10.1159/000319778DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Previously included in thesis in manuscript form, with title "Bilirubin and UGT1A1*28, are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting". 
  • Background: Bilirubin, an antioxidant, has been associated with reduced cardiovascular disease risk. A major cause of elevated plasma bilirubin is the common UGT1A1*28 promoter polymorphism in the gene of the bilirubin-conjugating enzyme UDP-glucuronosyltransferase-1A1, which reduces transcription by 70%. Earlier studies reporting a protective effect of bilirubin on stroke, have not included analysis of UGT1A1*28. The purpose of this study is to investigate if bilirubin and UGT1A1*28 are protective against ischemic stroke in a prospective case-referent setting.Methods: Cases with first-ever ischemic stroke (n=231; median lag time 4.9 years), and 462 matched referents from the The Northern Sweden Health and Disease Study Cohort were included. Plasma bilirubin was measured and UGT1A1*28 was analyzed by fragment analysis.Results: Plasma bilirubin was lower in cases than in referents, but the difference reached significance only for women. The UGT1A1*28 polymorphism (allele frequency 30%), showed a strong gene-dose relationship with bilirubin levels both among cases and referents, but was not associated with risk for stroke. Among multiple other variables analysed the strongest correlation with bilirubin was found for plasma iron.Conclusions: There was no evidence for a protective effect of the UGT1A1*28 polymorphism against stroke and consequently neither for bilirubin. The findings suggest that other factors influencing the risk for stroke also might affect bilirubin levels.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Marklund, Stefan L.Umeå universitet,Klinisk kemi(Swepub:umu)stma0003 (author)
  • Johansson, LarsDepartment of Medicine, Skellefteå County Hospital, Skellefteå, Sweden (author)
  • Osterman, PiaUmeå universitet,Patologi(Swepub:umu)pios0001 (author)
  • Hallmans, GöranUmeå universitet,Näringsforskning(Swepub:umu)goha0001 (author)
  • Weinehall, LarsUmeå universitet,Epidemiologi och global hälsa(Swepub:umu)lawe0001 (author)
  • Wiklund, Per-GunnarUmeå universitet,Medicin(Swepub:umu)pewi0010 (author)
  • Hultdin, JohanUmeå universitet,Klinisk kemi(Swepub:umu)johu0007 (author)
  • Umeå universitetKlinisk kemi (creator_code:org_t)

Related titles

  • In:Cerebrovascular Diseases: S. Karger30:6, s. 590-5961015-97701421-9786

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view